EP Patent

EP0304107A1 — Implant injection device

Assigned to Organon NV · Expires 1989-02-22 · 37y expired

What this patent protects

The invention relates to an injection device (1), in particular for once-only use, for injecting an implant (6) which can release a drug in a controlled manner, which device comprises a housing (2) which is provided at the injection end with an injection needle (3) in which the i…

USPTO Abstract

The invention relates to an injection device (1), in particular for once-only use, for injecting an implant (6) which can release a drug in a controlled manner, which device comprises a housing (2) which is provided at the injection end with an injection needle (3) in which the implant (6) can be disposed and in which a passage opening is disposed at the actuating end of the housing for a plunger (7,8), mounted in the housing and displaceable in the axial direction of the needle (3), which, on the one hand, can interact with the implant (6) and, on the other hand, is provided with an actuating element, which element is constructed as an element (10) for pressing and supporting against or on the part of the body to be treated.

Drugs covered by this patent

Patent Metadata

Patent number
EP0304107A1
Jurisdiction
EP
Classification
Expires
1989-02-22
Drug substance claim
No
Drug product claim
No
Assignee
Organon NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.